Johnson & Johnson - 63 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1962 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of April 25, 2025 is 154.58.
  • The all-time high Johnson & Johnson stock closing price was 170.24 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 169.99, which is 10% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 140.68, which is 9% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 155.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 155.4481 142.8760 167.7000 140.9320 154.5800 7.74%
2024 151.8204 153.8300 164.7290 139.9600 143.4720 -4.81%
2023 151.7393 166.3040 168.2260 138.8990 150.7240 -8.58%
2022 158.8975 155.9990 170.2430 144.7360 164.8660 5.97%
2021 148.5729 138.8230 161.1900 136.6270 155.5710 11.44%
2020 127.5635 126.0550 139.6030 96.5891 139.6030 10.82%
2019 114.8358 107.2960 126.4610 105.5910 125.9690 16.22%
2018 110.1942 113.8500 124.1700 98.9890 108.3880 -5.13%
2017 104.7669 92.3251 116.8430 89.0733 114.2510 24.43%
2016 89.3277 77.8819 98.6008 74.2157 91.8230 15.33%
2015 76.1654 78.6814 81.5792 69.8101 79.6182 1.14%
2014 74.8876 66.6776 81.6926 63.4474 78.7191 17.34%
2013 61.9165 50.3594 70.0470 50.2883 67.0878 34.62%
2012 46.7193 45.1624 51.1018 43.1417 49.8333 10.85%
2011 42.7649 41.5525 45.7253 38.4843 44.9567 9.89%
2010 40.3628 41.3249 42.5102 37.0449 40.9108 -0.59%
2009 36.3363 37.4915 41.5038 29.0452 41.1524 11.27%
2008 39.5182 39.6028 44.2756 34.2029 36.9846 -7.72%
2007 37.9398 38.9030 41.0989 35.3580 40.0774 3.61%
2006 36.0237 35.2783 40.2575 32.5135 38.6803 12.43%
2005 36.6540 35.3071 39.1243 34.3682 34.4025 -3.36%
2004 31.0816 28.4399 35.7898 27.3709 35.5990 25.17%
2003 28.6875 29.9186 31.8552 26.6989 28.4399 -2.08%
2002 30.9476 31.3133 35.0440 22.4702 29.0426 -7.88%
2001 27.5767 27.0352 32.5243 22.0655 31.5267 13.21%
2000 23.6606 24.4344 27.8470 18.1560 27.8470 12.67%
1999 24.9230 21.9164 28.1285 20.4089 24.7160 11.18%
1998 19.8845 17.2449 23.5895 16.9632 22.2311 27.32%
1997 15.8095 13.1862 17.7418 13.1862 17.4602 32.41%
1996 12.8665 11.1445 14.2464 11.0784 13.1862 16.59%
1995 9.0857 7.1755 12.1036 7.0768 11.3099 56.90%
1994 6.0660 5.9211 7.3301 4.8162 7.2084 22.76%
1993 5.4785 6.4384 6.4384 4.6547 5.8721 -10.60%
1992 6.4071 7.2752 7.5425 5.5961 6.5684 -11.49%
1991 5.8046 4.5273 7.4858 4.2443 7.4210 59.92%
1990 4.0596 3.8623 4.7395 3.3543 4.6405 21.16%
1989 3.2256 2.6935 3.8301 2.6935 3.8301 39.69%
1988 2.6080 2.5164 2.8384 2.2386 2.7418 13.69%
1987 2.7761 2.1701 3.3699 2.0775 2.4117 14.09%
1986 2.0521 1.6709 2.3795 1.5380 2.1138 24.71%
1985 1.4346 1.1475 1.7635 1.1313 1.6950 45.67%
1984 1.1045 1.3166 1.3649 0.9099 1.1636 -11.62%
1983 1.4709 1.5944 1.6467 1.2642 1.3166 -17.63%
1982 1.3156 1.1797 1.6427 1.0468 1.5984 33.67%
1981 1.1002 1.0723 1.2401 0.9180 1.1958 11.66%
1980 0.8521 0.8240 1.0736 0.7140 1.0709 25.87%
1979 0.7742 0.7972 0.8589 0.6952 0.8508 7.45%
1978 0.8240 0.8052 0.9529 0.7073 0.7918 -3.91%
1977 0.7553 0.8388 0.8388 0.6724 0.8240 -1.60%
1976 0.9269 0.9676 1.0320 0.7730 0.8374 -13.10%
1975 0.9552 0.8911 1.0629 0.7918 0.9636 10.98%
1974 1.0583 1.1998 1.2763 0.8066 0.8683 -28.28%
1973 1.2763 1.3796 1.4011 1.1220 1.2106 -13.60%
1972 1.2662 1.0495 1.4186 1.0186 1.4011 32.48%
1971 0.9139 0.6147 1.0616 0.6147 1.0576 72.81%
1970 0.5523 0.6281 0.6361 0.4013 0.6120 -5.00%
1969 0.4574 0.3785 0.6442 0.3623 0.6442 68.99%
1968 0.3166 0.3221 0.3812 0.2675 0.3812 16.08%
1967 0.2741 0.2016 0.3427 0.1980 0.3284 60.98%
1966 0.2072 0.2088 0.2386 0.1669 0.2040 -0.73%
1965 0.1656 0.1327 0.2082 0.1327 0.2055 54.16%
1964 0.1253 0.1245 0.1420 0.1145 0.1333 9.53%
1963 0.1072 0.0892 0.1415 0.0886 0.1217 39.24%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $379.479B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $796.425B 64.61
AbbVie (ABBV) United States $306.016B 17.09
Novo Nordisk (NVO) Denmark $260.636B 17.65
Roche Holding AG (RHHBY) Switzerland $248.102B 0.00
Novartis AG (NVS) Switzerland $234.183B 14.19
Merck (MRK) United States $196.697B 10.21
Sanofi (SNY) France $128.587B 12.24
Pfizer (PFE) United States $125.566B 7.12
Bayer (BAYRY) Germany $23.657B 4.39
Innoviva (INVA) United States $1.145B 10.56